Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Hospira announced a voluntary recall of 1% Lidocaine HCl for Injection after a confirmed report of particulate in a single unit. The particulate has been identified as human hair, embedded in and attached to a pinched area of the stopper.
If the particulate breaks and its pieces pass through the intravenous (IV) catheter, the material may lead to local inflammation, phlebitis, and/or low-level allergic response or microembolic effects.
The affected product has Lot #40-316-DK, NDC 0409-4279-02, and an expiration date of April 1, 2016. The recalled product is supplied as a 10mg/mL strength, in 30mL single-dose preservative-free units, and was distributed from May to June 2014.
RELATED: Discolored Lidocaine Solution Prompts Recall
Anyone with the affected product should discontinue use and distribution and quarantine the product. Hospira is notifying its direct customers via a letter and will arrange for return of all affected products.
For more information call (877) 546-5069 or visit Hospira.com.
